Evidence map›Paper›PMID 33918099›Full record

ArticlePharmaceutics2021

Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis.

Katrien Van Bocxlaer, Kerri-Nicola McArthur, Andy Harris, Mo Alavijeh, Stéphanie Braillard, Charles E Mowbray, Simon L Croft

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Quality of Life in Pediatric Cutaneous Leishmaniasis: The Role of Lesion Type, Location, and Treatment.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Katrien Van BocxlaerDepartment of Biology, York Biomedical Research Institute, University of York, York YO10 5DD, UK.
Kerri-Nicola McArthurPharmidex Pharmaceutical Services Ltd., London EC2V 8AU, UK.ORCID 0000-0002-3106-6171
Andy HarrisPharmidex Pharmaceutical Services Ltd., London EC2V 8AU, UK.
Mo AlavijehPharmidex Pharmaceutical Services Ltd., London EC2V 8AU, UK.
Stéphanie BraillardDrugs for Neglected Diseases initiative (DNDi), 1202 Geneva, Switzerland.ORCID 0000-0002-6354-3059
Charles E MowbrayDrugs for Neglected Diseases initiative (DNDi), 1202 Geneva, Switzerland.
Simon L CroftFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Pharmidex (United Kingdom) · GBDrugs for Neglected Diseases Initiative · CHUniversity of London · GBUniversity of York · GB

Funding

Medical Research Council MC-PC_17167Medical Research Council MC_PC_17167Medical Research Council MR/P027989/1Research Council United Kingdom Grand Challenges Research Funder MR/P027989/1
6 · The paper itself

Abstract

In cutaneous leishmaniasis (CL), parasites reside in the dermis, creating an opportunity for local drug administration potentially reducing adverse effects and improving treatment adherence compared to current therapies. Polymeric film-forming systems (FFSs) are directly applied to the skin and form a thin film as the solvent evaporates. In contrast to conventional topical dosage forms, FFSs strongly adhere to the skin, favouring sustained drug delivery to the affected site, reducing the need for frequent applications, and enhancing patient compliance. This study reports the first investigation of the use of film-forming systems for the delivery of DNDI-0690, a nitroimidazole compound with potent activity against CL-causing

Indexed as

antileishmanial activitycutaneous leishmaniasisDNDI-0690film-forming systemtopical treatment

Identifiers

PMID33918099
PMCPMC8069359
OpenAlexW3146011667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.